Bavarian Nordic A/S (Bavarian Nordic A/S) Marketable Securities : $57 Mil (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Bavarian Nordic A/S Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Bavarian Nordic A/S's Marketable Securities for the quarter that ended in Dec. 2023 was $57 Mil.

Bavarian Nordic A/S's annual Marketable Securities declined from Dec. 2021 ($475 Mil) to Dec. 2022 ($323 Mil) and declined from Dec. 2022 ($323 Mil) to Dec. 2023 ($57 Mil).

Bavarian Nordic A/S Marketable Securities Historical Data

The historical data trend for Bavarian Nordic A/S's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bavarian Nordic A/S Marketable Securities Chart

Bavarian Nordic A/S Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

26.00

226.33

474.82

323.19

57.10

Bavarian Nordic A/S Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Marketable Securities	Get a 7-Day Free Trial															323.19	244.45	80.49	67.84	57.10

Bavarian Nordic A/S Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Bavarian Nordic A/S (OTCPK:BVNRY) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Bavarian Nordic A/S Marketable Securities Related Terms

Thank you for viewing the detailed overview of Bavarian Nordic A/S's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Bavarian Nordic A/S (Bavarian Nordic A/S) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bavarian Nordic A/S (OTCPK:BVNRY) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

BVNKF:USA BAVAc:UK 0DPB:UK BAVA:Denmark BV3:Germany

Address

Philip Heymans Alle 3, Hellerup, DNK, DK-2900

Website

https://www.bavarian-nordic.com

Bavarian Nordic A/S is a biotechnology company focused on the development, manufacturing, and commercialization of cancer immunotherapies and vaccines for infectious diseases. The company has a specific focus on diseases for which the unmet medical need is high. Bavarian generates revenue through government research and development and supply contracts, and from its commercial partnerships. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets.